Shanghai Fosun Pharmaceutical (600196.SH) plans to repurchase A-shares worth 300 million to 600 million yuan.
Fosun Pharma (600196.SH) announced that the company plans to repurchase A shares worth 3 to 6 billion yuan, with repurchase price...
Shanghai Fosun Pharmaceutical (600196.SH) announced that the company plans to repurchase A-shares worth 300 million to 600 million yuan, with a maximum repurchase price of 30 yuan per share, to be used for the future conversion of convertible bonds, and/or implementation of equity incentive plans and/or employee stock plans.
Related Articles
MINTH GROUP (00425) signs strategic cooperation agreement with Siasun Robot & Automation to jointly develop European market.
Concept tracking of Hong Kong stocks | Deepening of capital market investment and financing reform Chinese securities firms sector valuation repair can be expected (with concept stocks)
KWUNGS AROMA (01925) And related redemption of 30 million yuan worth of fund shares.
MINTH GROUP (00425) signs strategic cooperation agreement with Siasun Robot & Automation to jointly develop European market.
Concept tracking of Hong Kong stocks | Deepening of capital market investment and financing reform Chinese securities firms sector valuation repair can be expected (with concept stocks)
KWUNGS AROMA (01925) And related redemption of 30 million yuan worth of fund shares.
RECOMMEND
Super Central Bank Week Arrives! Japan Leads With A Rate Hike As Developed Economies End The Rate‑Cut Cycle, Will The Fed Cut Alone Next Year?
16/12/2025
What Guidance Does The Economic Work Conference Offer For Cross‑Year Market Direction?
16/12/2025
Trade Surplus Tops One Trillion USD: New Challenges For China’s Foreign Trade | Instant Commentary
16/12/2025
